B, A., RE, A., Y, C., & KL, L. (2025). Sodium-glucose co-transporter inhibitors for APOL1 kidney disease: A call for studies. International urology and nephrology, 57(8), 2557. https://doi.org/10.1007/s11255-025-04443-z
Chicago Style (17th ed.) CitationB, Afsar, Afsar RE, Caliskan Y, and Lentine KL. "Sodium-glucose Co-transporter Inhibitors for APOL1 Kidney Disease: A Call for Studies." International Urology and Nephrology 57, no. 8 (2025): 2557. https://doi.org/10.1007/s11255-025-04443-z.
MLA (9th ed.) CitationB, Afsar, et al. "Sodium-glucose Co-transporter Inhibitors for APOL1 Kidney Disease: A Call for Studies." International Urology and Nephrology, vol. 57, no. 8, 2025, p. 2557, https://doi.org/10.1007/s11255-025-04443-z.
Warning: These citations may not always be 100% accurate.